183 related articles for article (PubMed ID: 10733462)
1. Research on humans faces scrutiny; new policies adopted.
Kefalides PT
Ann Intern Med; 2000 Mar; 132(6):513. PubMed ID: 10733462
[No Abstract] [Full Text] [Related]
2. Keeping research subjects out of harm's way.
Ellis GB
JAMA; 1999 Nov; 282(20):1963-5. PubMed ID: 10580465
[No Abstract] [Full Text] [Related]
3. Institutional Review Boards under stress: will they explode or change?
Phillips DF
JAMA; 1996 Nov; 276(20):1623-6. PubMed ID: 8922436
[No Abstract] [Full Text] [Related]
4. Lay participation in medical policy making. II. Human experimentation committees: professional or representative?
Veatch RM
Hastings Cent Rep; 1975 Oct; 5(5):31-40. PubMed ID: 1184371
[No Abstract] [Full Text] [Related]
5. Research ethics. NIH examines standards for consent.
Marshall E
Science; 1998 Jun; 280(5370):1688. PubMed ID: 9660706
[No Abstract] [Full Text] [Related]
6. When OPRR (Office for Protection from Research Risks) comes calling: enforcing Federal research regulations.
McCarthy CR
Kennedy Inst Ethics J; 1995 Mar; 5(1):51-5. PubMed ID: 10141718
[No Abstract] [Full Text] [Related]
7. Remodelling IRBs.
Silberner J
Hastings Cent Rep; 1998; 28(4):5. PubMed ID: 9762532
[No Abstract] [Full Text] [Related]
8. Oversight mechanisms for clinical research.
Snyderman R; Holmes EW
Science; 2000 Jan; 287(5453):595-7. PubMed ID: 10691540
[No Abstract] [Full Text] [Related]
9. Institutional review boards.
Levine RJ
BMJ; 1989 May; 298(6683):1268-9. PubMed ID: 2500193
[No Abstract] [Full Text] [Related]
10. Institutional review boards.
Waggoner WC
Clin Dermatol; 1991; 9(4):429-34. PubMed ID: 1822404
[No Abstract] [Full Text] [Related]
11. Review boards: a system 'in jeopardy'?
Marshall E
Science; 1998 Jun; 280(5371):1830-1. PubMed ID: 9669930
[No Abstract] [Full Text] [Related]
12. Institutional review of medical research. Cost-benefit analysis, risk-benefit analysis, and "the possible effects of research on public policy".
Schwartz RL
J Leg Med; 1983 Jun; 4(2):143-66. PubMed ID: 6411846
[No Abstract] [Full Text] [Related]
13. Neurobiological research involving human subjects: perspectives from the Office for Protection from Research Risks.
Puglisi JT; Ellis GB
Account Res; 1996; 4(3-4):261-5. PubMed ID: 11654521
[No Abstract] [Full Text] [Related]
14. Beyond localism: a proposal for a National Research Review Board.
Levine C; Caplan AL
IRB; 1986; 8(2):7-9. PubMed ID: 11649751
[No Abstract] [Full Text] [Related]
15. Institutional Review Board review and consent for research: what's behind the statistics?
Danis M; Grady C
Crit Care Med; 1998 Sep; 26(9):1488-9. PubMed ID: 9751583
[No Abstract] [Full Text] [Related]
16. Institutional review boards. A net too thin.
Palca J
Hastings Cent Rep; 1996; 26(3):4. PubMed ID: 8736666
[No Abstract] [Full Text] [Related]
17. The Office for Protection from Research Risks.
Porter JP
Kennedy Inst Ethics J; 1992 Sep; 2(3):279-82. PubMed ID: 10121091
[No Abstract] [Full Text] [Related]
18. Proposed model federal policy for protection of human subjects; response to the First Biennial Report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research.
U.S. Office of Science and Technology Policy
Fed Regist; 1986 Jun; 51(106):20204-17. PubMed ID: 11658721
[No Abstract] [Full Text] [Related]
19. The role of the institutional review board in research involving human subjects.
Bosso JA
Drug Intell Clin Pharm; 1983 Nov; 17(11):828-34. PubMed ID: 6641508
[TBL] [Abstract][Full Text] [Related]
20. From the Food and Drug Administration.
Nightingale SL
JAMA; 1999 Jan; 281(1):27. PubMed ID: 9892435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
